Clearant has a technology that we believe has huge potential.

The company's patented system solves the problem of how to use gamma radiation to kill pathogens in tissue and bone transplants, transfused blood and biopharmaceuticals without destroying the underlying materials.

It has long been known that radiation is effective in killing pathogens (viruses, bacteria, prions) but the problem is that the material itself is also destroyed or weakened by the radiation. As biomedical and biopharmaceutical innovation moves forward rapidly, more and more of these transplanted materials are being used and contamination looms as a major obstacle.


Our portfolio companies